Skip to content

Substance Abuse Treatment, Prevention, and Policy

ISSN 1747-597X

9 papers in the library · 294 citations · publishing 2006-2026

Papers

Sort Most recent Most cited

Kava (Piper methysticum) consumption patterns and conceptualizations: results from an online survey.

Substance Abuse Treatment, Prevention, and Policy May 5, 2026 Katherine G. W. Hill, Cianna J Piercey, Hollis C Karoly et al.

'Kava,' or 'kava kava,' (Piper methysticum) is a psychoactive plant indigenous to the Pacific Islands. Historical consumption is reported to provide anxiolytic and sedating effects. In regions where kava is native, it has been used in religious and cultural practices, as well as for medicinal purposes. The mechanisms by which kavalactones - the best studied psychoactive constituent of kava -...

DOI: 10.1186/s13011-026-00728-3 (opens in new tab) Full text (opens in new tab) Piper methysticum Alcohol Harm-reduction Kava +1

Initiation and/or re-initiation of drug use among people who use drugs in Vancouver, Canada from 2021 to 2022: a prospective cohort study.

Substance Abuse Treatment, Prevention, and Policy September 10, 2024 Anjali Sergeant, Paxton Bach, Jingxin Lei et al. 5 citations

Widespread health service disruptions resulting from the COVID-19 pandemic coincided with a dramatic increase in overdose deaths among people who use drugs (PWUD) in Vancouver, Canada. Those with a history of injection drug use are known to be at heightened risk of substance-associated harms. Drug use patterns and associated sociodemographic and health care utilization trends have been...

DOI: 10.1186/s13011-024-00624-8 (opens in new tab) Full text (opens in new tab) Covid-19 Drug overdose Substance-related disorders Vulnerable populations

Intravenous ketamine for severe alcohol use disorder at Moi Teaching & Referral Hospital, Kenya: a case report

Substance Abuse Treatment, Prevention, and Policy February 17, 2023 Florence Jaguga, Philip Kirwa, Benson N. Gakinya et al. 3 citations

BACKGROUND: Alcohol use disorder is prevalent globally and in Kenya, and is associated with significant health and socio-economic consequences. Despite this, available pharmacological treatment options are limited. Recent evidence indicates that intravenous (IV) ketamine can be beneficial for the treatment of alcohol use disorder, but is yet to be approved for this indication. Further, little...

Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy

Substance Abuse Treatment, Prevention, and Policy May 14, 2022 Victor Mocanu, Lindsay Mackay, Devon Christie et al. 27 citations

International drug policy is rapidly evolving in tandem with promising evidence for psychedelic-assisted psychotherapy (PAP) in treating a range of mental health conditions. Canada is among the countries increasingly expanding access to psychedelic substances for therapeutic purposes. The 8-year ban on medical exemptions through the Canadian Special Access Programme was recently reversed in...

DOI: 10.1186/s13011-022-00468-0 (opens in new tab) Psychotherapist Engineering ethics

Acute Toxic Effects of the New Psychoactive Substance "Voodoo" among Patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH), Egypt, during 2017.

Substance Abuse Treatment, Prevention, and Policy September 20, 2021 Rania Hussien, Maged El-Setouhy, Mohamed El Shinawi et al.

Voodoo is a heterogeneous mixture of psychoactive substances that has recently grown in popularity among youth in Egypt. Patients can present with a variety of manifestations that may lead to death in some cases. This study assessed the acute toxic effects of voodoo among patients presented to the Poison Control Center of Ain Shams University Hospitals (PCC-ASUH) during a one year period. This...

DOI: 10.1186/s13011-021-00408-4 (opens in new tab) Full text (opens in new tab) Egypt New psychoactive substances Toxicity Voodoo

Patterns of ecstasy use amongst live music event attendees and their opinions on pill testing: a cross sectional study.

Substance Abuse Treatment, Prevention, and Policy August 5, 2020 Madeleine Southey, Ashwini Kathirgamalingam, Benjamin Crawford et al.

Pill testing services could potentially be used to reduce drug-related harm. This study aims to identify patterns of ecstasy use among live music event attendees; explore the opinions and potential usage of illicit pill testing programs and examine factors associated with the likelihood of still taking a pill containing a potential harmful substance. A cross-sectional survey was completed by...

Mindfulness-based programs for substance use disorders: a systematic review of manualized treatments

Substance Abuse Treatment, Prevention, and Policy July 29, 2020 J. Richard Korecki, Frank J. Schwebel, Victoria R. Votaw et al. 141 citations

BACKGROUND: Substance use disorders are prevalent and returning to substance use (i.e., relapse) following treatment is common, underscoring the need for effective treatments that will help individuals maintain long-term reductions in substance use. Mindfulness-based interventions (MBIs) have been increasingly developed and evaluated for the treatment of substance use disorders. The aim of this...

DOI: 10.1186/s13011-020-00293-3 (opens in new tab) Mindfulness Health psychology Substance use Psychotherapist +3

Comparison of illegal drug use pattern in Taiwan and Korea from 2006 to 2014

Substance Abuse Treatment, Prevention, and Policy September 23, 2016 Ling‐yi Feng, Wenjing Yu, Wei-Ting Chang et al. 49 citations

While the problem of methamphetamine still lingers, NPS have emerged as a new issue in both countries. However, the NPS pattern was different between Taiwan and Korea. Although the controlled NPS items in Taiwan were far less than those in Korea, the quantity of total NPS seizures, especially with ketamine, was much larger in Taiwan than in Korea. Different NPS pattern may also imply they were...

DOI: 10.1186/s13011-016-0078-x (opens in new tab) Cannabis Heroin Environmental health Methamphetamine +1

Cannabis, motivation, and life satisfaction in an internet sample

Substance Abuse Treatment, Prevention, and Policy January 12, 2006 Sara Smucker Barnwell, Mitch Earleywine, Rand R. Wilcox 69 citations

Although little evidence supports cannabis-induced amotivational syndrome, sources continue to assert that the drug saps motivation 1, which may guide current prohibitions. Few studies report low motivation in chronic users; another reveals that they have higher subjective wellbeing. To assess differences in motivation and subjective wellbeing, we used a large sample (N = 487) and strict...

DOI: 10.1186/1747-597x-1-2 (opens in new tab) Normality Abstinence Clinical psychology Cannabis dependence +2